Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults

NCT07183709 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

NIH

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: PepGNP-COVID19
OTHER: Sterile Water for Injection

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)